531 related articles for article (PubMed ID: 33761944)
1. Delivery of cancer therapies by synthetic and bio-inspired nanovectors.
Briolay T; Petithomme T; Fouet M; Nguyen-Pham N; Blanquart C; Boisgerault N
Mol Cancer; 2021 Mar; 20(1):55. PubMed ID: 33761944
[TBL] [Abstract][Full Text] [Related]
2. Nanoplatform-based cascade engineering for cancer therapy.
Chen J; Zhu Y; Wu C; Shi J
Chem Soc Rev; 2020 Dec; 49(24):9057-9094. PubMed ID: 33112326
[TBL] [Abstract][Full Text] [Related]
3. Membrane-encapsulated camouflaged nanomedicines in drug delivery.
Ghosh S; Girigoswami K; Girigoswami A
Nanomedicine (Lond); 2019 Aug; 14(15):2067-2082. PubMed ID: 31355709
[TBL] [Abstract][Full Text] [Related]
4. Next-generation nanotheranostics targeting cancer stem cells.
Reda A; Hosseiny S; El-Sherbiny IM
Nanomedicine (Lond); 2019 Sep; 14(18):2487-2514. PubMed ID: 31490100
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterial-Enabled Cancer Therapy.
Quader S; Kataoka K
Mol Ther; 2017 Jul; 25(7):1501-1513. PubMed ID: 28532763
[TBL] [Abstract][Full Text] [Related]
6. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
[TBL] [Abstract][Full Text] [Related]
7. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
Choudhury NN; He H
Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
[TBL] [Abstract][Full Text] [Related]
10. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Shi Y; van der Meel R; Chen X; Lammers T
Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
[TBL] [Abstract][Full Text] [Related]
11. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
12.
Li C; Yang XQ; Zhang MZ; Song YY; Cheng K; An J; Zhang XS; Xuan Y; Liu B; Zhao YD
Theranostics; 2018; 8(20):5662-5675. PubMed ID: 30555572
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology synergized immunoengineering for cancer.
Chauhan DS; Dhasmana A; Laskar P; Prasad R; Jain NK; Srivastava R; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharm Biopharm; 2021 Jun; 163():72-101. PubMed ID: 33774162
[TBL] [Abstract][Full Text] [Related]
14. Exosome-like Nanovectors for Drug Delivery in Cancer.
Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
[TBL] [Abstract][Full Text] [Related]
15. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
17. Albumin Nanovectors in Cancer Therapy and Imaging.
Parodi A; Miao J; Soond SM; Rudzińska M; Zamyatnin AA
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31195727
[TBL] [Abstract][Full Text] [Related]
18. The emerging applications of magnetic nanovectors in nanomedicine.
Seeney CE
Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567
[TBL] [Abstract][Full Text] [Related]
19. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
20. Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.
Chung YH; Cai H; Steinmetz NF
Adv Drug Deliv Rev; 2020; 156():214-235. PubMed ID: 32603813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
